Anixa Biosciences is advancing its breast cancer vaccine programme towards [...]
Link Biologics has appointed Niall Martin to its board as [...]
Almirall delivered net sales growth of 12.4% in 2025, surpassing [...]
Abivax has presented new preclinical and clinical data for obefazimod [...]
Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been [...]
Lonza expands its Advanced Synthesis capabilities at Oss, integrating ADC [...]
Hansa Biopharma has reported a 135% increase in fourth-quarter revenue [...]
Evogene Ltd and Shanghai Lishan Biopharmaceuticals Co. have entered into [...]
Levicept has strengthened its executive team with the appointment of [...]
iOrganBio has appointed Karol Jarzabek as chief operating officer to [...]